Rhythm Metabolic, Inc.
Records under this name other than patents Rhythm Metabolic, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Rhythm Metabolic, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,845,339 | Method of Treating MELANOCORTIN-4 Receptor-Associated Disorders in Heterozygous Carriers Formerly held In force · High confidence | In force | High confidence | |
| US 10,167,312 | Method of Treating MELANOCORTIN-4 Receptor-Associated Disorders in Heterozygous Carriers Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,954,268 | Method of Treating MELANOCORTIN-4 Receptor-Associated Disorders in Heterozygous Carriers Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,702,448 | Method of Treating MELANOCORTIN-4 Receptor-Associated Disorders in Heterozygous Carriers Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,196,425 | Peptide compositions Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,858,399 | Peptide Compositions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,129,869 | Pharmaceutical Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 12,285,460 | Pharmaceutical Compositions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,077,612 | Peptide Compositions Formerly held In force · Medium confidence | In force | Medium confidence |